Cramer's 'Mad Money' Recap: Looking at the Bright Side
Scott Rutt
12/19/08 - 08:00 PM EST
Click here for an archive of Jim Cramer's Mad Money recaps.
"It's time to stop ignoring all of the positives in this market,"
Jim Cramer told viewer of his "Mad Money" TV show Friday.
He said
that in the daily foot race between the good news and the bad new,
it's time the good news to start garnering some attention.
"How can we not celebrate the total collapse of oil prices?"
Cramer asked viewers. He theorized that the decline in oil prices is
beginning to breathe new life into many tired stocks.
Cramer said that with
Darden Restaurants and BlackBerry maker
Research In Motion posting better-than-expected numbers, it's clear
that consumers are taking some of their gas and home heating savings
and spending it.
Cramer also cited Thursday's upbeat interview with
Costco's
(COST Quote) CEO
Jim Sinegal as further evidence that the American consumer may not
be dead after all.
Cramer said his strategy going forward is to buy stocks that
benefit from lower oil prices, such as
Walmart (WMT Quote), a
stock which he owns for his charitable trust
Action Alerts PLUS, and
Panera Bread (PNRA Quote).
Cramer also advocated that President Elect Obama take advantage of
the unprecedented decline in the price of oil to build a second strategic oil
reserve. That would allow the country to buy and store millions of additional
barrels of the precious commodity at today's extremely low prices.
Cramer: Auto Bailout Fallout Is Good |
| |
Speculation Friday
In this segment, Cramer featured the stock of
Sequenom (SQNM Quote), a
genetic testing company with potentially tremendous upside.
Sequenom is currently developing a non-invasive test for
chromosomal abnormalities such as Downs Syndrome. Cramer said that
unlike current invasive tests, like amniocentesis, which carry life
threatening risks to the fetus, Sequenom's tests captures fetal cells
in the mother's blood and carries no risk to mother or child.
Cramer said the new test could be revolutionary, allowing
prospective parents to test for Downs Syndrome in just 12 weeks
gestation instead of the current 20 weeks. The new test also doesn't
require pre-market FDA approval, making its June 2009 launch date more
certain.
Sequenom predicts the market for their new test could potentially
reach $1.2 billion a year in the U.S. and as much as $3.5 billion
worldwide. Cramer said the company could be a potential takeover
target if its trial data continues to be as promising as the 99.1%
detection rate the test is current achieving.
Outrage of the Day
Cramer again took aim at SEC
Chairman Chris Cox, who today held a press conference and in an
incredible act of selfishness and disloyalty, blamed his entire agency
for not discovering Bernie Madoff's alleged fraud sooner.
Cramer called the action "unbelievable" and renamed his "Wall of Shame" list of the worst CEOs to "The Cox-Madoff Memorial Wall of Shame."
In other Wall of Shame news, Cramer removed
Citigroup (C Quote) CEO
Vikram Pandit from the wall, saying that the government's bailout of
the company is the first one that may actually be good for
shareholders. He said the value of Citi's huge deposit base can now be
leveraged and the true value of the company might be unlocked.
Filling the newly-created top spot on the Wall of Shame is
Take-Two Interactive's
chairman Strauss Zelnick, who earlier in the year
rejected a takeover offer from rival
Electronic Arts at $25 a share because the deal "provided insufficient
value." Take-Two currently trades at $8.43 a share.
Lightning Round
Cramer was bullish on
ICx Technologies (ICXT Quote),
Ultra Petroleum (UPL Quote)
and
Corning (GLW Quote).
He was bearish on
Petrohawk Energy
(HK Quote).
Check out the latest edition of
"Cramer's Take on
Top-Searched Stocks" on Stockpickr.
Want more Cramer? Check out Jim's rules and commandments for investing by
clicking here.
Read more of Cramer's Mad Money Lightning Round insights.
For "Mad Money" performance statistics and other links, check out Mad Money stats